BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

383 related articles for article (PubMed ID: 27787717)

  • 1. Role of the Histamine H
    Schlicker E; Kathmann M
    Handb Exp Pharmacol; 2017; 241():277-299. PubMed ID: 27787717
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The histamine H3 receptor: from discovery to clinical trials with pitolisant.
    Schwartz JC
    Br J Pharmacol; 2011 Jun; 163(4):713-21. PubMed ID: 21615387
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The brain H3-receptor as a novel therapeutic target for vigilance and sleep-wake disorders.
    Parmentier R; Anaclet C; Guhennec C; Brousseau E; Bricout D; Giboulot T; Bozyczko-Coyne D; Spiegel K; Ohtsu H; Williams M; Lin JS
    Biochem Pharmacol; 2007 Apr; 73(8):1157-71. PubMed ID: 17288995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histamine H3-receptor inverse agonists as novel antipsychotics.
    Ito C
    Cent Nerv Syst Agents Med Chem; 2009 Jun; 9(2):132-6. PubMed ID: 20021346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of neurotransmitter release via histamine H3 heteroreceptors.
    Schlicker E; Malinowska B; Kathmann M; Göthert M
    Fundam Clin Pharmacol; 1994; 8(2):128-37. PubMed ID: 8020871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. H3 receptor antagonists/inverse agonists as anti-obesity agents.
    Hancock AA
    Curr Opin Investig Drugs; 2003 Oct; 4(10):1190-7. PubMed ID: 14649210
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Molecular imaging of histamine receptors in the human brain].
    Tashiro M; Yanai K
    Brain Nerve; 2007 Mar; 59(3):221-31. PubMed ID: 17370648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antihistamine agents and pitolisant might be useful for anorexia nervosa.
    Scolnick B
    Med Hypotheses; 2019 Nov; 132():109342. PubMed ID: 31421416
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histamine excites neurones in the human submucous plexus through activation of H1, H2, H3 and H4 receptors.
    Breunig E; Michel K; Zeller F; Seidl S; Weyhern CW; Schemann M
    J Physiol; 2007 Sep; 583(Pt 2):731-42. PubMed ID: 17627982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The histamine H(3) receptor: a target for new drugs].
    Arrang JM
    Ann Pharm Fr; 2003 May; 61(3):173-84. PubMed ID: 12714930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Morphine modulates the effects of histamine H1 and H3 receptors on seizure susceptibility in pentylenetetrazole-induced seizure model of mice.
    Amini-Khoei H; Rahimi-Balaei M; Amiri S; Haj-Mirzaian A; Hassanipour M; Shirzadian A; Gooshe M; Alijanpour S; Mehr SE; Dehpour AR
    Eur J Pharmacol; 2015 Dec; 769():43-7. PubMed ID: 26500121
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pitolisant (Wakix) for narcolepsy.
    Med Lett Drugs Ther; 2021 Feb; 63(1617):19-21. PubMed ID: 33647004
    [No Abstract]   [Full Text] [Related]  

  • 13. Constitutive activity of the histamine H3 receptor.
    Arrang JM; Morisset S; Gbahou F
    Trends Pharmacol Sci; 2007 Jul; 28(7):350-7. PubMed ID: 17573125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Novel Potent and Selective Histamine H
    Hino N; Marumo T; Kotani M; Shimazaki T; Kaku-Fukumoto A; Hikichi H; Karasawa JI; Tomishima Y; Komiyama H; Tatsuda E; Nozawa D; Nakamura T; Chaki S
    J Pharmacol Exp Ther; 2020 Nov; 375(2):276-285. PubMed ID: 32862143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histaminergic H3-Heteroreceptors as a Potential Mediator of Betahistine-Induced Increase in Cochlear Blood Flow.
    Bertlich M; Ihler F; Freytag S; Weiss BG; Strupp M; Canis M
    Audiol Neurootol; 2015; 20(5):283-93. PubMed ID: 26139562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histamine and selective H3-receptor ligands: a possible role in the mechanism and management of epilepsy.
    Vohora D; Pal SN; Pillai KK
    Pharmacol Biochem Behav; 2001 Apr; 68(4):735-41. PubMed ID: 11526971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Central Histamine, the H
    Díaz NF; Flores-Herrera H; García-López G; Molina-Hernández A
    CNS Neurol Disord Drug Targets; 2019; 18(7):516-522. PubMed ID: 31269888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histamine in migraine and brain.
    Alstadhaug KB
    Headache; 2014 Feb; 54(2):246-59. PubMed ID: 24433203
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pitolisant for treating patients with narcolepsy.
    Li S; Yang J
    Expert Rev Clin Pharmacol; 2020 Feb; 13(2):79-84. PubMed ID: 31937172
    [No Abstract]   [Full Text] [Related]  

  • 20. The histamine H3 receptor as a novel therapeutic target for cognitive and sleep disorders.
    Passani MB; Lin JS; Hancock A; Crochet S; Blandina P
    Trends Pharmacol Sci; 2004 Dec; 25(12):618-25. PubMed ID: 15530639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.